ArticleLeukemia & lymphoma2015

Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes.

Ohad Benjamini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.